Involvement of Smac, p53, and caspase pathways in induction of apoptosis by gossypol in human retinoblastoma cells

Molecular Vision

Volumn 18, Issue , 2012, Pages 2033-2042

  Hsiao, Wei Ting ^a,b   Tsai, Ming Dar ^a,c,d   Jow, Guey Mei ^a   Tien, Lu Tai ^a   Lee, Yih Jing ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4',6 DIAMIDINO 2 PHENYLINDOLE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DEATH RECEPTOR 5; GOSSYPOL; PROTEIN P53; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL STRESS; CELL SURVIVAL; CELL VIABILITY; CELLULAR PARAMETERS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA DEGRADATION; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL STRESS; NUCLEAR CONDENSATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RETINOBLASTOMA; SIGNAL TRANSDUCTION; TUMOR CELL; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GOSSYPOL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOCHONDRIAL PROTEINS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RETINAL NEOPLASMS; RETINOBLASTOMA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84865832319     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Melamud A, Palekar R, Singh A. Retinoblastoma. Am Fam Physician 2006; 73:1039-44. [PMID: 16570739]
2. Young JLSM, Roffers SD, Liff JM, Bunin GR. Editors. Retinoblastoma. Bethesda, MD, USA National Cancer Institute, SEER Program. NIH Pub. No. 99-4649; 1999.
3. Chen YH, Lin HY, Hsu WM, Lee SM, Cheng CY. Retinoblastoma in Taiwan: incidence and survival characteristics from 1979 to 2003. Eye (Lond) 2010; 24:318-22. [PMID: 19373260]
4. Balmer A, Munier F. Differential diagnosis of leukocoria and strabismus, first presenting signs of retinoblastoma. Clin Ophthalmol 2007; 1:431-9. [PMID: 19668520]
5. Lin P, O'Brien JM. Frontiers in the management of retinoblastoma. Am J Ophthalmol 2009; 148:192-8. [PMID: 19477707]
6. Gombos DS, Chevez-Barrios AP. Current treatment and management of retinoblastoma. Curr Oncol Rep 2007; 9:453, 6. [PMID: 17991352]
7. Wang X, Howell CP, Chen F, Yin J, Jiang Y. Gossypol-a polyphenolic compound from cotton plant. Adv Food Nutr Res 2009; 58:215-63. [PMID: 19878861]
8. Shandilya L, Clarkson TB, Adams MR, Lewis JC. Effects of gossypol on reproductive and endocrine functions of male cynomolgus monkeys (Macaca fascicularis). Biol Reprod 1982; 27:241-52. [PMID: 7115850]
9. Lian J, Karnak D, Xu L. The Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells. Autophagy 2010; 6:1201-3. [PMID: 20930561]
10. Meng Y, Tang W, Dai Y, Wu X, Liu M, Ji Q, Ji M, Pienta K, Lawrence T, Xu L. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa. Mol Cancer Ther 2008; 7:2192-202. [PMID: 18645028]
11. Volate SR, Kawasaki BT, Hurt EM, Milner JA, Kim YS, White J, Farrar WL. Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumorinitiating cells. Mol Cancer Ther 2010; 9:461-70. [PMID: 20124455]
12. Gao P, Bauvy C, Souquere S, Tonelli G, Liu L, Zhu Y, Qiao Z, Bakula D, Proikas-Cezanne T, Pierron G, Codogno P, Chen Q, Mehrpour M. The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells. J Biol Chem 2010; 285:25570-81. [PMID: 20529838]
13. Wang X, Wang J, Wong SC, Chow LS, Nicholls JM, Wong YC, Liu Y, Kwong DL, Sham JS, Tsa SW. Cytotoxic effect of gossypol on colon carcinoma cells. Life Sci 2000; 67:2663-71. [PMID: 11105982]
14. Sung B, Ravindran J, Prasad S, Pandey MK, Aggarwal BB. Gossypol Induces Death Receptor-5 through Activation of the ROS-ERK-CHOP Pathway and Sensitizes Colon Cancer Cells to TRAIL. J Biol Chem 2010; 285:35418-27. [PMID: 20837473]
15. Li ZM, Jiang WQ, Zhu ZY, Zhu XF, Zhou JM, Liu ZC, Yang DJ, Guang ZZ. Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin's lymphoma cells. Cancer Biol Ther 2008; 7:51-60. [PMID: 17938578]
16. Mohammad RM, Wang S, Aboukameel A, Chen B, Wu X, Chen J, Al-Katib A. Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma. Mol Cancer Ther 2005; 4:13-21. [PMID: 15657349]
17. Moon DO, Kim MO, Lee JD, Kim GY. Gossypol suppresses NF-kappaB activity and NF-kappaB-related gene expression in human leukemia U937 cells. Cancer Lett 2008; 264:192-200. [PMID: 18314260]
18. Chang JS, Hsu YL, Kuo PL, Chiang LC, Lin CC. Upregulation of Fas/Fas ligand-mediated apoptosis by gossypol in an immortalized human alveolar lung cancer cell line. Clin Exp Pharmacol Physiol 2004; 31:716-22. [PMID: 15554914]
19. Mohammad RM, Wang S, Banerjee S, Wu X, Chen J, Sarkar FH. Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line. Pancreas 2005; 31:317-24. [PMID: 16258364]
20. Kitada S, Leone M, Sareth S, Zhai D, Reed JC, Pellecchia M. Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J Med Chem 2003; 46:4259-64. [PMID: 13678404]
21. Goldsmith KC, Hogarty MD. Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma. Cancer Lett 2005; 228:133-41. [PMID: 15927359]
22. Reed JC, Pellecchia M. Apoptosis-based therapies for hematologic malignancies. Blood 2005; 106:408-18. [PMID: 15797997]
23. Buron N, Porceddu M, Brabant M, Desgue D, Racoeur C, Lassalle M, Pechoux C, Rustin P, Jacotot E, Borgne-Sanchez A. Use of human cancer cell lines mitochondria to explore the mechanisms of BH3 peptides and ABT-737-induced mitochondrial membrane permeabilization. PLoS ONE 2010; 5:e9924. [PMID: 20360986]
24. Giuliano M, Vento R, Lauricella M, Calvaruso G, Carabillo M, Tesoriere G. Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells. Eur J Biochem 1996; 236:523-32. [PMID: 8612625]
25. Bach LA, Headey SJ, Norton RS. IGF-binding proteins-the pieces are falling into place. Trends Endocrinol Metab 2005; 16:228-34. [PMID: 15935690]
26. Bach LA. IGFBP-6 five years on; not so 'forgotten'? Growth Horm IGF Res 2005; 15:185-92. [PMID: 15914054]
27. Karaca B, Kucukzeybek Y, Gorumlu G, Erten C, Gul MK, Cengiz E, Atmaca H, Uzunoglu S, Sanli UA, Karabulut B, Uslu R. Profiling of angiogenic cytokines produced by hormone-and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol. Eur Cytokine Netw 2008; 19:176-84. [PMID: 19103523]
28. Benz CC, Iyer SB, Asgari HS, Matlin SA, Aronson FR, Barchowsky A. Gossypol effects on endothelial cells and tumor blood flow. Life Sci 1991; 49:PL67-72. [PMID: 1875793]
29. Zhang XQ, Huang XF, Hu XB, Zhan YH, An QX, Yang SM, Xia AJ, Yi J, Chen R, Mu SJ, Wu DC. Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro. Asian J Androl 2010; 12:697-708. [PMID: 20657602]
30. Chang CJ, Ghosh PK, Hu YF, Brueggemeier RW, Lin YC. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats. Res Commun Chem Pathol Pharmacol 1993; 79:293-312. [PMID: 8480076]